Skip to main content
Caplight Logo









Synchronicity Pharma

Synchronicity Pharma

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://synchronicitypharma.com/

Last Round

Convertible Debt

Jan 11, 2022

Total Funding Raised

$31.69M

Company Overview

Synchronicity Pharma is a biotechnology company that develops novel therapeutics focused on modulating circadian clock genes for the treatment of sleep-wake disorders and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

circadian biologydrug discoverysmall-molecule therapeuticsbiotechorexin modulatorscryptochrome modulatorssleep-wake disorderscomputational drug discoveryin-silico drug designoncology therapeuticsmetabolic diseaseclinical-stage biotechpharma licensingCRY modulators

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synchronicity Pharma Comparables

Compare Synchronicity Pharma with similar companies based on industry and business-model similarity.

Synchronicity Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eli Lilly and Company
77%
Alkermes plc
72%
Jazz Pharmaceuticals
67%

Synchronicity Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJan 11, 2022
VC RoundOct 23, 2019
Series BFeb 1, 2016
VC RoundJul 25, 2014
Series ADec 5, 2013

Key People

Founding team and executive leadership

Remy Sukhija

Chief Executive Officer

Executive Team

Synchronicity Pharma Investors

Notable investors and investment history

Synchronicity Pharma investors
InvestorRounds
Bay City CapitalSeries B, Series A
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors increased 48% MoM.

  • Jan 11, 2022

    $1.6M raised from Alkermes plc.

Synchronicity Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synchronicity Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synchronicity Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Jose, California
Employee Range4
Year Founded2008
Last FundingJan 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?